LEADER 03575nam 2200817z- 450 001 9910557502103321 005 20210501 035 $a(CKB)5400000000044535 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69280 035 $a(oapen)doab69280 035 $a(EXLCZ)995400000000044535 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAdvances in Celiac Disease 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (128 p.) 311 08$a3-03943-384-9 311 08$a3-03943-385-7 330 $aThe incidence of gluten-related disorders (GRDs) continues to increase and its global prevalence is estimated affect to 5% of the population. s. Celiac disease (CD), Dermatitis Herpetiformis (DH), Gluten Ataxia (GA), wheat allergy (WA), and Non-Celiac Gluten Sensitivity (NCGS) are the five major GRDs that present with a wide range of clinical manifestations. They are manifested by symptoms of gastrointestinal tract disorders, as well as hematological, dermatological endocrinological, gynecological, rheumatological and nervous system. NCGS is a term that is used to describe individuals who are not affected by celiac disease or wheat allergy, yet they have intestinal and/or extra-intestinal symptoms related to gluten ingestion with improvement of their symptoms upon withdrawing gluten from their diet. It is believed that represents some heterogeneous groups with different subgroups characterized by different etiologies, clinical histories and clinical courses. There also appears to be an overlap between NCGS and irritable bowel syndrome (IBS). There is a need for establishing strict criteria for diagnosing NCGS. The absence of validated biomarkers remains a significant limitation for research studies on NCGS. New evidence shows that a gluten-free diet may be beneficial for some patients with gastrointestinal symptoms, such as those symptoms commonly found in patients with IBS. 606 $aMedicine and Nursing$2bicssc 610 $aAAA 610 $aAGA 610 $aanemia 610 $aanti-DGP 610 $aanti-tTG 610 $aAsia 610 $aceliac disease 610 $achildren 610 $adermatitis herpetiformis 610 $adiagnosis 610 $aenteropathy 610 $afirst-degree relatives 610 $aFODMAP 610 $afolic acid 610 $agluten 610 $agluten-free diet 610 $agluten-related disorders 610 $agut 610 $aHLA-DQ 610 $aHLA-DQB1*02 610 $aIgA deficiency 610 $aIL-17A 610 $airon 610 $airritable bowel disease 610 $alevel of evidences 610 $along-term GFD therapy (LTGFD) 610 $aLTGFD with good compliance (LTGFDWGC) 610 $alymphoma 610 $an/a 610 $aNCGS 610 $anon-celiac gluten sensitivity 610 $anon-celiac gluten-sensitivity 610 $aprevalence 610 $ascreening 610 $aself-report 610 $asurvey studies 610 $avitamin B12 610 $avitamin D 610 $awheat 610 $awheat allergy 615 7$aMedicine and Nursing 700 $aRodrigo$b Luis$4edt$01289236 702 $aRodrigo$b Luis$4oth 906 $aBOOK 912 $a9910557502103321 996 $aAdvances in Celiac Disease$93021123 997 $aUNINA